Large-scale testing (Phase 3)WithdrawnNCT06461949
What this trial is testing
Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray
Who this might be right for
Allergic Fungal Rhinosinusitis (AFRS)Chronic Rhinosinusitis (CRS)Asthma+1 more
National Institute on Deafness and Other Communication Disorders (NIDCD)